These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26101399)

  • 1. Using aripiprazole to treat new-onset hyperprolactinemia-related delusion of pregnancy.
    Hu LY; Lee YT; Lu T; Hung MB; Hung YY
    Aust N Z J Psychiatry; 2015 Oct; 49(10):946. PubMed ID: 26101399
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of symptomatic hyperprolactinemia by aripiprazole.
    Wahl R; Ostroff R
    Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the addition of aripiprazole on hyperprolactinemia associated with risperidone long-acting injection.
    Ziadi Trives M; Bonete Llácer JM; García Escudero MA; Martínez Pastor CJ
    J Clin Psychopharmacol; 2013 Aug; 33(4):538-41. PubMed ID: 23775053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of sexual adverse effects induced by atypical antipsychotic medication.
    Downing L; Kim DD; Procyshyn RM`; Tibbo P
    J Psychiatry Neurosci; 2019 Jul; 44(4):287-288. PubMed ID: 31245972
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia: A case series.
    Naono-Nagatomo K; Naono H; Abe H; Takeda R; Funahashi H; Uchimura D; Ishida Y
    Asian J Psychiatr; 2017 Feb; 25():36-41. PubMed ID: 28262171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole relieves catatonia but worsens hallucination in a patient with catatonic schizophrenia.
    Lin CH; Tsai YF; Huang WL
    Asia Pac Psychiatry; 2016 Jun; 8(2):176. PubMed ID: 27062667
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
    Bai YM; Chen TT; Lin WK; Chang WH; Wu B; Hung CH; Chou P; Chen JY
    J Clin Psychopharmacol; 2007 Jun; 27(3):306-8. PubMed ID: 17502783
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole treatment of risperidone-induced hyperprolactinemia.
    Chen JX; Su YA; Wang SL; Bian QT; Liu YH; Wang N; Yang FD; Haile C; Kosten TR; Zhang XY
    J Clin Psychiatry; 2009 Jul; 70(7):1058-9. PubMed ID: 19653986
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperprolactinaemia on depot risperidone treated with aripiprazole.
    Anandarajan T; Tibrewal P; Dhillon R; Bastiampillai T
    Aust N Z J Psychiatry; 2012 Aug; 46(8):792-3. PubMed ID: 22528973
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.
    Robinson DG; Gallego JA; John M; Petrides G; Hassoun Y; Zhang JP; Lopez L; Braga RJ; Sevy SM; Addington J; Kellner CH; Tohen M; Naraine M; Bennett N; Greenberg J; Lencz T; Correll CU; Kane JM; Malhotra AK
    Schizophr Bull; 2015 Nov; 41(6):1227-36. PubMed ID: 26338693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.
    Lin SK; Chen CK
    J Clin Psychiatry; 2006 Aug; 67(8):1307. PubMed ID: 16965214
    [No Abstract]   [Full Text] [Related]  

  • 16. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
    Lai YC; Chiou CC; Chen CH; Huang MC
    J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
    [No Abstract]   [Full Text] [Related]  

  • 17. The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
    Peng PW; Huang MC; Tsai CJ; Pan CH; Chen CC; Chiu CC
    J Clin Psychopharmacol; 2008 Dec; 28(6):726-7; author reply 727-8. PubMed ID: 19011459
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of the CYP2D6 phenotype on hyperprolactinemia development as an adverse event of treatment with atypical antipsychotic agents in pediatric patients.
    Grădinaru R; Andreescu N; Nussbaum L; Suciu L; Puiu M
    Ir J Med Sci; 2019 Nov; 188(4):1417-1422. PubMed ID: 30771137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels.
    Tasaki M; Yasui-Furukori N; Yokoyama S; Shinozaki M; Sugawara N; Shimoda K
    Neuropsychopharmacol Rep; 2021 Sep; 41(3):379-384. PubMed ID: 34189861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Risperidone-Associated Hyperprolactinemia With Aripiprazole.
    Mazher OA; Maneta E; Hall W
    J Clin Psychopharmacol; 2018 Oct; 38(5):529-531. PubMed ID: 30106879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.